{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:34:08Z","timestamp":1788572048945,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.ppat.1006601","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000}}],"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK 1071"],"award-info":[{"award-number":["GRK 1071"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1AI089956"],"award-info":[{"award-number":["RO1AI089956"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1006601","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T17:47:19Z","timestamp":1504115239000},"page":"e1006601","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":102,"title":["Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus"],"prefix":"10.1371","volume":"13","author":[{"given":"Anna","family":"Bootz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4624-218X","authenticated-orcid":true,"given":"Astrid","family":"Karbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1503-7709","authenticated-orcid":true,"given":"Johannes","family":"Spindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kropff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Sticht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Britt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8457-5850","authenticated-orcid":true,"given":"Michael","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","author":"A Kenneson","year":"2007","journal-title":"Reviews in Medical Virology"},{"key":"ref2","first-page":"26","article-title":"Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe","volume":"14","author":"A Ludwig","year":"2009","journal-title":"Euro Surveill Bull Eur sur les Mal Transm = Eur Commun Dis Bull"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","article-title":"Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection","volume":"164","author":"AM Dreher","year":"2014","journal-title":"J Pediatr"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","article-title":"Cytomegalovirus infections in solid organ transplantation: a review","volume":"45","author":"P Ramanan","year":"2013","journal-title":"Infect Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: A CIBMTR analysis","volume":"127","author":"P Teira","year":"2016","journal-title":"Blood"},{"key":"ref6","first-page":"1","article-title":"???? T Cells Confer Protection against Murine Cytomegalovirus (MCMV)","volume":"11","author":"C Khairallah","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1586\/14787210.2016.1173540","article-title":"Optimum treatment of congenital cytomegalovirus infection","volume":"14","author":"M Leruez-Ville","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00430-015-0388-z","article-title":"The history of vaccination against cytomegalovirus","author":"S Plotkin","year":"2015","journal-title":"Medical Microbiology and Immunology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","author":"SA Plotkin","year":"2010","journal-title":"Clinical and Vaccine Immunology"},{"key":"ref10","first-page":"215","article-title":"Cytomegaloviruses","author":"M Mach","year":"2013"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"A Macagno","year":"2010","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/v6031346","article-title":"HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex","volume":"6","author":"M Zydek","year":"2014","journal-title":"Viruses"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01701-15","article-title":"Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH\/gL Pentamer Potently Block Primary Cytotrophoblast Infection","volume":"89","author":"F Chiuppesi","year":"2015","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1415310111","article-title":"Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies","volume":"111","author":"A Kabanova","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004524","article-title":"Human Cytomegalovirus Vaccine Based on the Envelope gH\/gL Pentamer Complex","volume":"10","author":"F Wussow","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.3390\/v7122957","article-title":"Herpesvirus gB: A finely tuned fusion machine","author":"RS Cooper","year":"2015","journal-title":"Viruses"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"RF Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: A phase 2 randomised placebo-controlled trial","volume":"377","author":"PD Griffiths","year":"2011","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/JVI.00883-10","article-title":"Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques","volume":"85","author":"K Abel","year":"2011","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/S0264-410X(03)00037-9","article-title":"Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity","volume":"21","author":"JD Shanley","year":"2003","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2016.03.005","article-title":"Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection","volume":"34","author":"RD Cardin","year":"2016","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.vaccine.2013.07.010","article-title":"Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model","volume":"32","author":"MR Schleiss","year":"2014","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/320714","article-title":"Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs","volume":"183","author":"a Chatterjee","year":"2001","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial","volume":"34","author":"DI Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/315022","article-title":"A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant","volume":"180","author":"RF Pass","year":"1999","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/IAI.21.3.840-842.1978","article-title":"Protective effect of early serum from mice after cytomegalovirus infection","volume":"21","author":"TP Araullo-Cruz","year":"1978","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/infdis\/143.2.231","article-title":"Modification by adoptive humoral immunity of murine cytomegalovirus infection","volume":"143","author":"JD Shanley","year":"1981","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1099\/0022-1317-72-1-149","article-title":"Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies","volume":"72","author":"HE Farrell","year":"1991","journal-title":"J Gen Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1084\/jem.179.5.1713","article-title":"Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus","volume":"179","author":"S Jonji\u0107","year":"1994","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"12172","DOI":"10.1128\/JVI.01214-08","article-title":"Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice","volume":"82","author":"D Cekinovi\u0107","year":"2008","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2007-06-095414","article-title":"Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells","volume":"110","author":"K Klenovsek","year":"2007","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e1002172","DOI":"10.1371\/journal.ppat.1002172","article-title":"B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies","volume":"7","author":"S P\u00f6tzsch","year":"2011","journal-title":"PLoS Pathog"},{"issue":"Pt 5","key":"ref33","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1099\/0022-1317-68-5-1457","article-title":"Human monoclonal antibodies neutralizing human cytomegalovirus","volume":"68","author":"Y Masuho","year":"1987","journal-title":"J Gen Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/JVI.02393-14","article-title":"Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus","volume":"89","author":"A-K Wiegers","year":"2015","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1128\/JVI.00434-13","article-title":"Characterization of a discontinuous neutralizing epitope on glycoprotein B of human cytomegalovirus","volume":"87","author":"N Spindler","year":"2013","journal-title":"J Virol"},{"key":"ref36","article-title":"Crystal Structure of the Human Cytomegalovirus Glycoprotein B","volume":"11","author":"HG Burke","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1073\/pnas.94.26.14759","article-title":"Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome","volume":"94","author":"M Messerle","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"10346","DOI":"10.1128\/JVI.00545-11","article-title":"Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2","volume":"85","author":"S Jordan","year":"2011","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1086\/368094","article-title":"Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation","volume":"187","author":"S Mathys","year":"2003","journal-title":"J Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003493","article-title":"The Viral Chemokine MCK-2 of Murine Cytomegalovirus Promotes Infection as Part of a gH\/gL\/MCK-2 Complex","volume":"9","author":"FM Wagner","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2005-05-1833","article-title":"Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination","volume":"107","author":"S Noda","year":"2006","journal-title":"Blood"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.chom.2014.02.002","article-title":"Cytomegalovirus hijacks CX3CR1hi patrolling monocytes as immune-privileged vehicles for dissemination in mice","volume":"15","author":"LP Daley-Bauer","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e1004377","DOI":"10.1371\/journal.ppat.1004377","article-title":"Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody","volume":"10","author":"N Spindler","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jamapediatrics.2015.3235","article-title":"Outcomes of Respiratory Syncytial Virus Immunoprophylaxis in Infants Using an Abbreviated Dosing Regimen of Palivizumab","volume":"170","author":"PM Lavoie","year":"2016","journal-title":"JAMA Pediatr"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"M Caskey","year":"2015","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.1128\/JVI.78.14.7536-7544.2004","article-title":"Gain of virulence caused by loss of a gene in murine cytomegalovirus","volume":"78","author":"I Bubi\u0107","year":"2004","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00430-008-0077-2","article-title":"The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence","author":"AE Campbell","year":"2008","journal-title":"Medical Microbiology and Immunology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.68.10.6305-6311.1994","article-title":"Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice","volume":"68","author":"TM Collins","year":"1994","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4161\/mabs.2.3.11788","article-title":"Stability of IgG isotypes in serum","author":"IR Correia","year":"2010","journal-title":"mAbs"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"F Klein","year":"2012","journal-title":"Nature"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/CVI.00230-14","article-title":"Nonneutralizing functional antibodies: A new \u201cold\u201d paradigm for HIV vaccines","author":"JL Excler","year":"2014","journal-title":"Clinical and Vaccine Immunology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection","volume":"19","author":"CJ Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/1570162X113116660057","article-title":"Protective Antiviral Antibodies that Lack Neutralizing Activity: Precedents and Evolution of Concepts","volume":"11","author":"AL Schmaljohn","year":"2013","journal-title":"Curr Hiv Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.it.2015.04.005","article-title":"Fc??R dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities","author":"F Nimmerjahn","year":"2015","journal-title":"Trends in Immunology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin g subclass activity through selective Fc receptor binding","volume":"310","author":"F Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00281-014-0448-2","article-title":"CMV-encoded Fc\u03b3 receptors: modulators at the interface of innate and adaptive immunity","volume":"36","author":"E Corrales-Aguilar","year":"2014","journal-title":"Semin Immunopathol"},{"key":"ref57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: From structure to effector functions","volume":"5","author":"G Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/1521-4141(2002010)32:10<2954::AID-IMMU2954>3.0.CO;2-2","article-title":"Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: Identification of a CMV-responsive element in the CD46 promoter region","volume":"32","author":"M Nomura","year":"2002","journal-title":"Eur J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/514050","article-title":"Neutralization of Cytomegalovirus Virions: The Role of Complement","volume":"176","author":"OB Spiller","year":"1997","journal-title":"J Infect Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nrmicro1972","article-title":"Avoiding the void: cell-to-cell spread of human viruses","volume":"6","author":"Q Sattentau","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcv.2006.05.007","article-title":"Evidence for direct transfer of cytoplasmic material from infected to uninfected cells during cell-associated spread of human cytomegalovirus","volume":"37","author":"M Digel","year":"2006","journal-title":"J Clin Virol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1073\/pnas.0409597102","article-title":"Human cytomegalovirus cell-to-cell spread in the absence of an essential assembly protein","volume":"102","author":"MC Silva","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1099\/vir.0.006668-0","article-title":"Murine cytomegalovirus displays selective infection of cells within hours after systemic administration","volume":"90","author":"KM Hsu","year":"2009","journal-title":"J Gen Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial","volume":"34","author":"DI Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"ref65","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1523234113","article-title":"Two distinct trimeric conformations of natively membrane-anchored full-length herpes simplex virus 1 glycoprotein B","volume":"113","author":"T Zeev-Ben-Mordehai","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"E4120","DOI":"10.1073\/pnas.1501880112","article-title":"Limits and patterns of cytomegalovirus genomic diversity in humans","volume":"112","author":"N Renzette","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.1128\/JVI.01644-09","article-title":"Optimal replication of human cytomegalovirus correlates with endocytosis of glycoprotein gpUL132","volume":"84","author":"B Kropff","year":"2010","journal-title":"J Virol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"5.6.1","DOI":"10.1002\/0471250953.bi0506s47","article-title":"Comparative protein structure modeling using MODELLER","volume":"2014","author":"B Webb","year":"2014","journal-title":"Curr Protoc Bioinforma"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics","volume":"14","author":"W Humphrey","year":"1996","journal-title":"J Mol Graph"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1006601","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1006601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T18:06:06Z","timestamp":1602871566000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1006601"}},"subtitle":[],"editor":[{"given":"Sallie R.","family":"Permar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":69,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1006601","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1006601","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]}}}